VBI Vaccines Inc.
NASDAQ:VBIV
Overview | Financials
| Company Name | VBI Vaccines Inc. |
| Symbol | VBIV |
| Currency | USD |
| Price | 0.065 |
| Market Cap | 1,872,954 |
| Dividend Yield | 0% |
| 52-week-range | 0.057 - 1.35 |
| Industry | Biotechnology |
| Sector | Healthcare |
| CEO | Mr. Jeffery R. Baxter FCMA |
| Website | https://www.vbivaccines.com |
An error occurred while fetching data.
About VBI Vaccines Inc.
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The company's enveloped
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD









